These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30755335)

  • 1. Pacemakers are associated with a higher risk of late death and transplantation in the Fontan population.
    Poh CL; Celermajer DS; Grigg LE; Kalman JM; McGuire MA; Gentles TL; Radford DJ; Bullock A; Disney PJS; Winlaw D; du Plessis K; d'Udekem Y
    Int J Cardiol; 2019 May; 282():33-37. PubMed ID: 30755335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pacemaker-Related Factors and Outcomes of Fontan Patients　- Impact of Paced QRS Duration.
    Shin H; Baek JS; Kim MJ; Cha S; Yu JJ
    Circ J; 2024 Apr; 88(5):642-648. PubMed ID: 38267052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand.
    d'Udekem Y; Iyengar AJ; Galati JC; Forsdick V; Weintraub RG; Wheaton GR; Bullock A; Justo RN; Grigg LE; Sholler GF; Hope S; Radford DJ; Gentles TL; Celermajer DS; Winlaw DS
    Circulation; 2014 Sep; 130(11 Suppl 1):S32-8. PubMed ID: 25200053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three decades later: The fate of the population of patients who underwent the Atriopulmonary Fontan procedure.
    Poh CL; Zannino D; Weintraub RG; Winlaw DS; Grigg LE; Cordina R; Hornung T; Bullock A; Justo RN; Gentles TL; Verrall C; du Plessis K; Celermajer DS; d'Udekem Y
    Int J Cardiol; 2017 Mar; 231():99-104. PubMed ID: 28100430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device management of arrhythmias after Fontan conversion.
    Tsao S; Deal BJ; Backer CL; Ward K; Franklin WH; Mavroudis C
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):937-40. PubMed ID: 19660377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes after first-onset arrhythmia in Fontan physiology.
    Carins TA; Shi WY; Iyengar AJ; Nisbet A; Forsdick V; Zannino D; Gentles T; Radford DJ; Justo R; Celermajer DS; Bullock A; Winlaw D; Wheaton G; Grigg L; d'Udekem Y
    J Thorac Cardiovasc Surg; 2016 Nov; 152(5):1355-1363.e1. PubMed ID: 27751239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes in Adolescents and Adults After the Fontan Procedure.
    Dennis M; Zannino D; du Plessis K; Bullock A; Disney PJS; Radford DJ; Hornung T; Grigg L; Cordina R; d'Udekem Y; Celermajer DS
    J Am Coll Cardiol; 2018 Mar; 71(9):1009-1017. PubMed ID: 29495980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unsatisfactory Early and Late Outcomes After Fontan Surgery Delayed to Adolescence and Adulthood.
    Forsdick V; Iyengar AJ; Carins T; Gentles TL; Weintraub RG; Celermajer DS; d'Udekem Y
    Semin Thorac Cardiovasc Surg; 2015; 27(2):168-74. PubMed ID: 26686444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of the pulmonary arteries at or prior to the Fontan procedure is not associated with worse long-term outcomes: a propensity-matched analysis from the Australia-New Zealand Fontan Registry†.
    Shearer L; Justo RN; Marathe SP; Betts K; Venugopal P; Winlaw DS; Bullock A; Robertson T; Gentles TL; Celermajer D; d'Udekem Y; Alphonso N
    Eur J Cardiothorac Surg; 2019 May; 55(5):829-836. PubMed ID: 30496386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart transplantation in Fontan patients across Australia and New Zealand.
    Shi WY; Yong MS; McGiffin DC; Jain P; Ruygrok PN; Marasco SF; Finucane K; Keogh A; d'Udekem Y; Weintraub RG; Konstantinov IE
    Heart; 2016 Jul; 102(14):1120-6. PubMed ID: 27000055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fontan conversion with arrhythmia surgery.
    Kim WH; Lim HG; Lee JR; Rho JR; Bae EJ; Noh CI; Yoon YS; Kim YJ
    Eur J Cardiothorac Surg; 2005 Feb; 27(2):250-7. PubMed ID: 15691678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Ventricular Pacing on Morbidity in Adults After Fontan Repair.
    Kochav JD; Rosenbaum M; Kochav SM; Slater E; Wassercug-Zemer N; Lewis MJ
    Am J Cardiol; 2020 Apr; 125(8):1263-1269. PubMed ID: 32081367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent pacing post-Fontan is not associated with reduced long-term survival.
    Hall SJ; Cullington D; Thomson JDR; Bentham JR
    Cardiol Young; 2019 Dec; 29(12):1432-1434. PubMed ID: 31601284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical therapy of arrhythmias in single-ventricle patients undergoing Fontan or Fontan conversion.
    Kwak JG; Kim WH; Lee JR; Kim YJ
    J Card Surg; 2009; 24(6):738-41. PubMed ID: 20078722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extracardiac conduit Fontan procedure in Australia and New Zealand: hypoplastic left heart syndrome predicts worse early and late outcomes.
    Iyengar AJ; Winlaw DS; Galati JC; Wheaton GR; Gentles TL; Grigg LE; Justo RN; Radford DJ; Weintraub RG; Bullock A; Celermajer DS; d'Udekem Y;
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):465-73; discussion 473. PubMed ID: 24578409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mid-term surgical results of Fontan conversion with antiarrhythmia surgery.
    Jang WS; Kim WH; Choi K; Nam J; Choi ES; Lee JR; Kim YJ; Kwon BS; Kim GB; Bae EJ
    Eur J Cardiothorac Surg; 2014 May; 45(5):922-7. PubMed ID: 24188968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permanent pacemaker implantation after pediatric heart transplantation: Risk factors, indications, and outcomes.
    Mahmood A; Andrews R; Fenton M; Morrison A; Mangat J; Davies B; Burch M; Simmonds J
    Clin Transplant; 2019 Apr; 33(4):e13503. PubMed ID: 30790343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year outcomes of Fontan conversion in Australia and New Zealand demonstrate the superiority of a strategy of early conversion.
    Poh CL; Cochrane A; Galati JC; Bullock A; Celermajer DS; Gentles T; du Plessis K; Winlaw DS; Hornung T; Finucane K; d'Udekem Y
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):530-5; discussion 535. PubMed ID: 25838458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterotaxy Is Not a Risk Factor for Adverse Long-Term Outcomes After Fontan Completion.
    Marathe SP; Zannino D; Cao JY; du Plessis K; Marathe SS; Ayer J; Celermajer DS; Gentles TL; Sholler GF; Justo RN; Alphonso N; d'Udekem Y; Winlaw DS
    Ann Thorac Surg; 2020 Aug; 110(2):646-653. PubMed ID: 31891693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
    Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
    Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.